What is it about?

In this study, we aimed to determine CCR6 lymphocyte expression in AMI patients and its association with disease severity using the Gensini scoring system. We found that The chemokine receptor CCR6 is an independent biomarker for AMI and may play a role as a mediator of T lymphocyte recruitment, which is associated with coronary lesion destabilization.

Featured Image

Read the Original

This page is a summary of: Assessment of Circulating CCR6 Level in Acute Myocardial Infarction and its Association with Disease Severity, Cardiovascular & Hematological Agents in Medicinal Chemistry, November 2023, Bentham Science Publishers,
DOI: 10.2174/1871525721666230120160717.
You can read the full text:

Read

Contributors

The following have contributed to this page